Myriad Genetics (MYGN) Tops Q3 EPS by 5c
Tweet
Share
E-mail
Get Alerts MYGN Hot Sheet
Price: $5.85 -0.17%
Revenue Growth %: -3.3%
Financial Fact:
Interest income: 300K
Today's EPS Names:
CCEL, FNGR, FAST, More
Revenue Growth %: -3.3%
Financial Fact:
Interest income: 300K
Today's EPS Names:
CCEL, FNGR, FAST, More
Join SI Premium – FREE
Myriad Genetics (NASDAQ: MYGN) reported Q3 EPS of ($0.03), $0.05 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $191.9 million versus the consensus estimate of $179.23 million.
For earnings history and earnings-related data on Myriad Genetics (MYGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citigroup (C) Tops Q2 EPS by 42c
- Ligand completes $739M acquisition of XOMA Royalty
- Tractor Supply Company (TSCO) PT Lowered to $33 at UBS
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
